Search for: "Janssen Research " Results 41 - 60 of 204
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
5 Jan 2018, 12:00 pm by Tom Lamb
Categories: SGLT-2 Inhibitors Diabetes Drugs Hepatitis C Treatment Drugs Anticoagulants / Bloodthinners Breast Implants Osteoporosis Treatment Drugs Erectile Dysfunction (ED) Drugs Heartburn / Acid Reflux Drugs Multiple Sclerosis (MS) Treatment Drugs DPP-4 Inhibitors Diabetes Drugs Miscellaneous   SGLT-2 Inhibitors Diabetes Drugs: Jardiance - Amputations Drug Safety Issue Remains Uncertain Due To Admitted "inherent limitations of... post hoc analyses" (11/28/17) Medical… [read post]
5 Jan 2018, 5:00 am by melissalafreniere
Johnson and Johnson’s Janssen Pharmaceuticals and Bayer Health Care market Xarelto and together they shared the news of the failed phase three study in a press release last October. [read post]
29 Dec 2017, 5:00 am by melissalafreniere
Janssen and Johnson & Johnson made billions off the drug and it is still prescribed currently. [read post]
21 Dec 2017, 5:00 am by melissalafreniere
Some research studies, however, show the dangers of improper monitoring of the patient, all of which can make a person more likely to suffer serious internal bleeding and a host of other side effects. [read post]
19 Dec 2017, 5:00 am by melissalafreniere
Drug makers were hit with thousands of lawsuits alleging Risperdal caused gynecomastia and further research has discovered increased risk of that condition and others linked to the drug. [read post]
19 Dec 2017, 5:00 am by melissalafreniere
Drug makers were hit with thousands of lawsuits alleging Risperdal caused gynecomastia and further research has discovered increased risk of that condition and others linked to the drug. [read post]
18 Dec 2017, 12:11 pm by Jeff Rasansky
Pre-market research conducted by the Johnson & Johnson subsidiary Janssen revealed the tendency of the drug to cause gynecomastia, yet warnings on the drug’s labels greatly understate the potential risk of breast development in males who take the medication. [read post]
18 Dec 2017, 12:11 pm by Jeff Rasansky
Pre-market research conducted by the Johnson & Johnson subsidiary Janssen revealed the tendency of the drug to cause gynecomastia, yet warnings on the drug’s labels greatly understate the potential risk of breast development in males who take the medication. [read post]
15 Dec 2017, 5:00 am by melissalafreniere
The drug is manufactured and distributed by Janssen, Johnson & Johnson, and Bayer. [read post]
15 Dec 2017, 5:00 am by melissalafreniere
The drug is manufactured and distributed by Janssen, Johnson & Johnson, and Bayer. [read post]
7 Dec 2017, 5:00 am by melissalafreniere
Further, say researchers and physicians, Risperidone is not a “cure for autism. [read post]
29 Nov 2017, 5:00 am by melissalafreniere
The lawsuits allege that drug makers discarded research results that did not support their marketing claims. [read post]
17 Nov 2017, 5:00 am by melissalafreniere
The makers of Xarelto, Janssen, Johnson & Johnson, and Bayer, were hit with a lawsuit alleging that the drug caused rectal bleeding. [read post]
14 Nov 2017, 5:00 am by melissalafreniere
A new lawsuit has been filed against Janssen Research & Development and Johnson & Johnson Pharmaceutical Research alleging that the plaintiff sustained severe gastrointestinal bleeding from Xarelto. [read post]
3 Nov 2017, 5:00 am by Scott
After sustaining those injuries and medical care for internal bleeding, she filed a lawsuit against Janssen Pharmaceuticals and Johnson & Johnson, the makers of Xarelto. [read post]
2 Nov 2017, 9:00 pm by News Desk
Several top experts are attending the workshop, with funding from the Janssen Vaccines and the College of Agricultural Sciences’ Office for Research and Graduate Education. [read post]
26 Oct 2017, 5:00 am by melissalafreniere
The lawsuit has been filed against Johnson and Johnson Research and Development, also known as Janssen R&D. [read post]
24 Oct 2017, 12:30 pm by Tom Lamb
Future Clinical Trials And Investigations Need To Clarify Whether This Amputation Drug Injury Could Be A Class Effect Of All SGLT2 Inhibitors   (Posted by Tom Lamb at DrugInjuryWatch.com)   During this year we have written several times about the still developing drug safety issue of lower limb amputations linked to Invokana use:  A "Dear Doctor" Letter For Invokana Amputations Side Effect Was Sent September 2017 By Janssen In Canada Analysis Of FDA Adverse Event… [read post]
13 Oct 2017, 2:05 pm by melissalafreniere
  The lawsuit was filed in the eastern district of Louisiana against Janssen Research & Development and Johnson & Johnson, the makers of Xarelto. [read post]